dacarbazine has been researched along with Cholera Infantum in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (40.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buesa, JM; Carrasco, JA; Casado, A; Cruz, J; Cubedo, R; de Andrés, R; De Juan, A; Fra, J; García-Del-Muro, X; Gómez-España, A; Laínez, N; López-Pousa, A; Martín, J; Martínez-Trufero, J; Maurel, J; Meana, A; Pericay, C; Poveda, A; Rubió, J | 1 |
Ambinder, RF; Gladstone, DE; Gocke, CD; Habermann, TM; Herman, JM; Jacene, HA; Jones, RJ; Kasamon, YL; Link, BK; Matsui, WH; Perkins, B; Popplewell, LL; Swinnen, LJ | 1 |
Chuang, HH; Copeland, AR; Dabaja, BS; Dang, N; Fanale, MA; Fayad, LE; Feng, L; Goy, A; Hagemeister, F; Kwak, LW; Macapinlac, HA; McLaughlin, P; Neelapu, SS; Oki, Y; Pro, B; Rodriguez, MA; Romaguera, J; Samaniego, F; Younes, A; Yuan, Y | 1 |
Bedikian, AY; Eton, O; Papadopoulos, N; Plager, C; Ring, S | 1 |
Bamberg, M; Dichgans, J; Küker, WM; Steinbach, JP; Weller, M; Wick, W | 1 |
Czarnetzki, BM; Kolde, G | 1 |
Engstrom, PF; Klaassen, DJ; MacIntyre, JM; Mittelman, A | 1 |
Blum, RH; Canellos, GP; Corson, JM; Frei, E; Greenberger, JS; Wilson, RE | 1 |
Aviles, A; Delgado, S | 1 |
Baker, LH; Cummings, G; Haas, CD; Samson, MK | 1 |
8 trial(s) available for dacarbazine and Cholera Infantum
Article | Year |
---|---|
Randomized phase II study comparing gemcitabine plus dacarbazine versus dacarbazine alone in patients with previously treated soft tissue sarcoma: a Spanish Group for Research on Sarcomas study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Dacarbazine; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Female; Gastrointestinal Diseases; Gemcitabine; Hematologic Diseases; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Proportional Hazards Models; Salvage Therapy; Sarcoma; Soft Tissue Neoplasms; Spain; Treatment Outcome; Young Adult | 2011 |
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocyte Subsets; Bleomycin; Clone Cells; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Epstein-Barr Virus Infections; Fatigue; Female; Gastrointestinal Diseases; Herpesvirus 4, Human; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Neutropenia; Remission Induction; Rituximab; Survival Rate; Vinblastine; Young Adult | 2012 |
Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Alopecia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxorubicin; Fatigue; Female; Gastrointestinal Diseases; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lung Diseases; Male; Middle Aged; Neutropenia; Remission Induction; Rituximab; Survival Rate; Vinblastine; Young Adult | 2012 |
Phase II evaluation of temozolomide in metastatic choroidal melanoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Choroid Neoplasms; Dacarbazine; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Prospective Studies; Temozolomide; Treatment Outcome | 2003 |
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Feasibility Studies; Female; Gastrointestinal Diseases; Glioblastoma; Hematologic Diseases; Humans; Male; Middle Aged; Prospective Studies; Remission Induction; Salvage Therapy; Supratentorial Neoplasms; Survival Analysis; Temozolomide; Treatment Outcome | 2004 |
[High-dosage metoclopramide versus lorazepam in cytostatic-induced gastrointestinal side effects].
Topics: Anti-Anxiety Agents; Dacarbazine; Gastrointestinal Diseases; Humans; Lorazepam; Metoclopramide | 1983 |
Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278).
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Colonic Neoplasms; Dacarbazine; Drug Administration Schedule; Female; Fluorouracil; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hydroxyurea; Male; Middle Aged; Mitomycins; Random Allocation; Razoxane; Rectal Neoplasms; Semustine; Time Factors | 1984 |
A prospective clinical trial comparing chemotherapy, radiotherapy and combined therapy in the treatment of early stage Hodgkin's disease with bulky disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Follow-Up Studies; Gastrointestinal Diseases; Hematologic Diseases; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Life Tables; Lymphoma; Neoplasms, Second Primary; Nervous System Diseases; Prospective Studies; Pulmonary Fibrosis; Radiation Injuries; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine | 1998 |
2 other study(ies) available for dacarbazine and Cholera Infantum
Article | Year |
---|---|
Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD).
Topics: Adult; Aged; Alopecia; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Leukopenia; Lung Neoplasms; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1980 |
Dibromodulcitol (DBD), DTIC, and actinomycin-D in disseminated malignant melanoma. A phase I-II clinical trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Dactinomycin; Drug Evaluation; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Melanoma; Middle Aged; Mitolactol | 1985 |